Suppressing the NLRP3 inflammasome reduces COVID-19-like pathology, indicating that NLRP3 inflammasome activation plays an important role in the pathogenesis of SARS-CoV-2 infection [264]. This evidence concerns the gene NLRP3 and COVID-19.